TRAWTraws Pharma Inc. Common Stock

0.5300USD-1.85%Mkt Cap: 8.15M $P/E:

Traws Pharma, Inc., a clinical-stage biopharmaceutical company, develops small synthetic molecules for respiratory viral diseases and cancer. The company is developing investigational novel therapies for influenza and CO…